AHA 2023

Hot Topics in CAD/PAD

MINT: Liberal or restrictive transfusion strategy in MI with anaemia? 

Presented By

Dr Jeffrey Carson, Rutgers University, NJ, USA

Trial

Phase 3, MINT

Conference

AHA 2023

Type

Peer-reviewed article

29 January 2024 13:52

ORBITA-2 confirms PCI effective for symptom relief in patients with stable angina 

Presented By

Dr Christopher Rajkumar, Imperial College London, UK

Trial

ORBITA-2

Conference

AHA 2023

Type

Peer-reviewed article

29 January 2024 13:48

Nicotinamide riboside shows promising trend for walking function in PAD 

Presented By

Prof. Mary McDermott, Northwestern University, USA

Trial

Phase 2, NICE

Conference

AHA 2023

Type

Peer-reviewed article

29 January 2024 13:43

Pemafibrate reduces microvascular complications of PAD and T2D 

Presented By

Dr Aruna Pradhan, Brigham and Women’s Hospital, USA

Trial

Phase 3, PROMINENT

Conference

AHA 2023

Type

Peer-reviewed article

29 January 2024 13:39

Dapagliflozin improves cardiometabolic outcomes in myocardial infarction  

Presented By

Prof. Stefan James, Uppsala University, Sweden

Trial

Phase 3, DAPA-MI

Conference

AHA 2023

Type

Peer-reviewed article

29 January 2024 13:33

Optimising Hypertension Outcomes

Edoxaban versus warfarin in chronic thromboembolic pulmonary hypertension

Presented By

Dr Kazuya Hosokawa, Kyushu University, Japan

Trial

Phase 3, KABUKI

Conference

AHA 2023

Type

Peer-reviewed article

29 January 2024 14:09

Sodium intake and blood pressure: new insights

Presented By

Dr Deepak Gupta, Vanderbilt University Medical Centre, USA

Trial

CARDIA-SSBP

Conference

AHA 2023

Type

Peer-reviewed article

29 January 2024 14:04

Intensive BP intervention reduces risk of dementia 

Presented By

Dr Jiang He, Tulane University, USA

Conference

AHA 2023

Type

Peer-reviewed article

29 January 2024 14:01

Post-partum intervention lowers BP after hypertensive pregnancy 

Presented By

Dr Jamie Kitt, University of Oxford, UK

Trial

POP-HT

Conference

AHA 2023

Type

Peer-reviewed article

29 January 2024 13:58

Biannual zilebesiran associated with substantial BP reductions 

Presented By

Prof. George Bakris, University of Chicago, USA

Trial

Phase 2, KARDIA-1

Conference

AHA 2023

Type

Peer-reviewed article

29 January 2024 13:56

Future of Lipid-Lowering Therapies

Encouraging data for lepodisiran as Lp(a) lowering therapy 

Presented By

Dr Steven Nissen, Cleveland Clinic, USA

Trial

Phase 1

Conference

AHA 2023

Type

Peer-reviewed article

29 January 2024 14:38

Gene editing may change the treatment landscape of hypercholesterolaemia 

Presented By

Dr Andrew Bellinger, Verve Therapeutics, USA

Trial

Phase 1, heart-1

Conference

AHA 2023

Type

Peer-reviewed article

29 January 2024 14:35

REPRIEVE: Mechanisms behind MACE reduction in HIV population on pitavastatin

Presented By

Dr Michael Lu, Massachusetts General Hospital, USA

Trial

Phase 3, REPRIEVE

Conference

AHA 2023

Type

Peer-reviewed article

29 January 2024 14:31

Recaticimab may offer a solution for uncontrolled hypercholesterolaemia

Presented By

Dr Xin Du, Beijing Anzhen Hospital, China

Trial

Phase 3, REMAIN-2

Conference

AHA 2023

Type

Peer-reviewed article

29 January 2024 14:27

Atrial Fibrillation and Sudden Cardiac Death

Abelacimab substantially lowers bleeding risk compared with rivaroxaban 

Presented By

Dr Christian Ruff, Brigham and Women’s Hospital, USA

Trial

Phase 2, AZALEA-TIMI 71

Conference

AHA 2023

Type

Peer-reviewed article

29 January 2024 15:22

Liraglutide may improve post-ablation outcomes in obese patients with AF

Presented By

Dr Jeffrey Goldberger, University of Miami, USA

Trial

Phase 4, LEAF

Conference

AHA 2023

Type

Peer-reviewed article

29 January 2024 15:19

Single or dual cardioversion in patients with obesity and AF?

Presented By

Dr Joshua Aymond, Ochsner Health, USA

Conference

AHA 2023

Type

Peer-reviewed article

29 January 2024 15:16

NOAH-AFNET 6: Does the duration of AHRE influence response to edoxaban?

Presented By

Dr Nina Becher, University of Hamburg, Germany

Trial

Phase 3, NOAH-AFNET 6

Conference

AHA 2023

Type

Peer-reviewed article

29 January 2024 15:13

ARTESIA: How useful is anticoagulation in subclinical AF? 

Presented By

Prof. Jeff Healey, McMaster University, Canada

Trial

Phase 4, ARTESIA

Conference

AHA 2023

Type

Peer-reviewed article

29 January 2024 15:08

Jewel IDE: High compliance rates for novel patch wearable cardioverter defibrillator

Presented By

Dr John Hummel, Ohio State University, USA

Trial

Jewel IDE

Conference

AHA 2023

Type

Peer-reviewed article

29 January 2024 15:04

Sudden cardiac death in athletes: incidence, causes, and trends over 20 years

Presented By

Dr Bradley Petek, Oregon Health and Science University, USA

Conference

AHA 2023

Type

Peer-reviewed article

29 January 2024 15:01

Miscellaneous Trials

Successful results for semaglutide in the highly anticipated SELECT trial 

Presented By

Dr Michael Lincoff, Cleveland Clinic, USA

Trial

Phase 3, SELECT

Conference

AHA 2023

Type

Peer-reviewed article

29 January 2024 15:37

Can a walking intervention improve functional status and quality of life in HFrEF?

Presented By

Dr Tomas Vetrovsky, Charles University, Czechia

Trial

WATCHFUL

Conference

AHA 2023

Type

Peer-reviewed article

29 January 2024 15:30

Head-to-head: Surgical embolectomy versus ultrasound-assisted thrombolysis in high-risk pulmonary embolism

Presented By

Dr Stefan Stortecky, University of Bern, Switzerland

Trial

Phase 2, SPECIAL

Conference

AHA 2023

Type

Peer-reviewed article

29 January 2024 15:26